NCI backs development of lung cancer test

08/27/2013 | GenomeWeb Daily News (free registration)

Insight Genetics will use a $1.5 million grant from the National Cancer Institute to further develop its non-small cell lung cancer diagnostic test. Specifically, Insight said it will develop a panel of tests for detecting and characterizing oncogenic DEPDC1, RET and ROS1 in NSCLC patients who have tested triple negative for KRAS, EGFR or ALK gene mutations.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ